Samantha Hinsley

Adjuvant zoledronic acid in patients with early breast cancer: final efficacy analysis of the AZURE (BIG 01/04) randomised open-label phase 3 trial

Robert E. Coleman, David Cameron, David Dodwell et al. · The Lancet Oncology · 2014 · 296 citations

Medicine, Oncology, Pharmacology +10

Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE)

Aline Talhouk, Joshy George, Chen Wang et al. · Clinical Cancer Research · 2020 · 75 citations · Full text

Medicine, Bioinformatics, Oncology +17

Early phase clinical trials extension to guidelines for the content of statistical analysis plans

Victoria Homer, Christina Yap, Simon Bond et al. · BMJ · 2022 · 64 citations · Full text

Pharmacy, Biostatistics, Clinical Data Management +13

Adjuvant zoledronic acid reduces fractures in breast cancer patients; an AZURE (BIG 01/04) study

Caroline Wilson, R. Bell, Samantha Hinsley et al. · European Journal of Cancer · 2018 · 55 citations · Full text

Medicine, Oncology, Pharmacology +10

The SABRTooth feasibility trial protocol: a study to determine the feasibility and acceptability of conducting a phase III randomised controlled trial comparing stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I non-small cell lung cancer (NSCLC) considered to be at higher risk of complications from surgical resection

M. Snee, Lucy McParland, Fiona Collinson et al. · Pilot and Feasibility Studies · 2016 · 46 citations · Full text

Medicine, Oncology, Surgery +17